The impact of MeCP2 loss-or gain-of-function on synaptic plasticity

Neuropsychopharmacology

Volumn 38, Issue 1, 2013, Pages 212-219

  Na, Elisa S ^a   Nelson, Erika D ^a   Kavalali, Ege T ^b   Monteggia, Lisa M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

behavior; long term potentiation; MeCP2 duplication syndrome; Rett syndrome; synaptic transmission

Indexed keywords

METHYL CPG BINDING PROTEIN 2; REGULATOR PROTEIN;

CELL STRUCTURE; GAIN OF FUNCTION MUTATION; GENE DUPLICATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; LOSS OF FUNCTION MUTATION; METHYL CPG BINDING PROTEIN 2 DUPLICATION SYNDROME; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT INFECTION; RETT SYNDROME; REVIEW; SEIZURE;

ANIMALS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; NEURONAL PLASTICITY; RETT SYNDROME; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84869092521     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.116     Document Type: Review

References (58)

1. Adachi M, Autry AE, Covington 3rd HE, Monteggia LM (2009). MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J Neurosci 29: 4218-4227.
2. Akhtar MW, Raingo J, Nelson ED, Montgomery RL, Olson EN, Kavalali ET et al (2009) Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J Neurosci 29: 8288-8297.
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghti HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat Genet 23: 185-188
4. Armstrong D, Dunn JK, Antalffy B, Trivedi R (1995) Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 54: 195-201.
5. Armstrong DD (2001) Rett syndrome neuropathology review 2000. Brain Dev 23(Suppl 1): S72-S76.
6. Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM (2006). Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 21: 217-227.
7. Belichenko PV, Dahlstrom A (1995). Studies on the 3-dimensional architecture of dendritic spines and varicosities in human cortex by confocal laser scanning microscopy and Lucifer yellow microinjections. J Neurosci Methods 57: 55-61.
8. Budisteanu M, Papuc SM, Tutulan-Cunita A, Budisteanu B, Arghir A (2011). Novel clinical finding in MECP2 duplication syndrome. Eur Child Adolesc Psychiatry 20: 373-375.
9. Calfa G, Percy AK, Pozzo-Miller L (2011). Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) 236: 3-19.
10. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J et al (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224-1229.
11. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J et al (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468: 263-269.
12. Chao HT, Zoghbi HY (2012). MeCP2: only 100% will do. Nat Neurosci 15: 176-177.
13. Chao HT, Zoghbi HY, Rosenmund C (2007). MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56: 58-65.
14. Chapleau CA, Calfa GD, Lane MC, Albertson AJ, Larimore JL, Kudo S et al (2009). Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis 35: 219-233.
15. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27: 327-331.
16. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC et al (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889.
17. Citri A, Malenka RC (2008). Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33: 18-41.
18. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL et al (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13: 2679-2689.
19. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB (2005). Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 102: 12560-12565.
20. Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y (2005). Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64: 537-544.
21. Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P et al (2008). Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59: 947-958.
22. Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM (2006). Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry 59: 468-476.
23. Guy J, Cheval H, Selfridge J, Bird A (2011). The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27: 631-652.
24. Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007). Reversal of neurological defects in a mouse model of Rett sydrome. Science 315: 1143-1147.
25. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322-326.
26. Hagberg G, Stenbom Y, Engerstrom IW (2001). Head growth in Rett syndrome. Brain Dev 23(Suppl 1): S227-S229.
27. Kavalali ET, Nelson ED, Monteggia LM (2011). Role of MeCP2, DNA methylation, and HDACs in regulating synapse function. J Neurodev Disord 3: 250-256.
28. Kishi N, Macklis JD (2004). MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27: 306-321.
29. Kishi N, Macklis JD (2010). MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp Neurol 222: 51-58.
30. Kriaucionis S, Bird A (2003). DNA methylation and Rett syndrome. Hum Mol Genet 12 Spec No 2: R221-R227.
31. Lasalle JM, Yasui DH (2009). Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 1: 119-130.
32. Li H, Zhong X, Chau KF, Williams EC, Chang Q (2011). Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat Neurosci 14: 1001-1008.
33. Luikenhuis S, Giacometti E, Beard CF, Jaenisch R (2004). Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci USA 101: 6033-6038.
34. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y et al (2003). DNA methylationrelated chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890-893.
35. Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B et al (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 26: 319-327.
36. Na ES, Monteggia LM (2011). The role of MeCP2 in CNS development and function. Horm Behav 59: 364-368.
37. Na ES, Nelson ED, Adachi M, Autry AE, Mahgoub MA, Kavalali ET et al (2012). A Mouse Model for MeCP2 Duplication Syndrome: MeCP2 Overexpression Impairs Learning and Memory and Synaptic Transmission. J Neurosci 32: 3109-3117.
38. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN et al (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.
39. Nelson ED, Bal M, Kavalali ET, Monteggia LM (2011). Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission. J Neurophysiol 106: 193-201.
40. Nelson ED, Kavalali ET, Monteggia LM (2006). MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol 16: 710-716.
41. Pelka GJ, Watson CM, Radziewic T, Hayward M, Lahooti H, Christodoulou J et al (2006). Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 129(Part 4): 887-898.
42. Ramocki MB, Peters SU, Tavyev YJ, Zhang F, Carvalho CM, Schaaf CP et al (2009). Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 66: 771-782.
43. Ramocki MB, Tavyev YJ, Peters SU (2010) The MECP2 duplication syndrome. Am J Med Genet A 152A: 1079-1088.
44. Reardon W, Donoghue V, Murphy AM, King MD, Mayne PD, Horn N et al (2010) Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28. Eur J Pediatr 169: 941-949.
45. Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, Ren J et al (2009). Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci USA 106: 21966-21971.
46. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J et al (2002). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35: 243-254.
47. Smyk M, Obersztyn E, Nowakowska B, Nawara M, Cheung SW, Mazurczak T et al (2008). Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections. Am J Med Genet B Neuropsychiatr Genet 147B: 799-806.
48. Stearns NA, Schaevitz LR, Bowling H, Nag N, Berger UV, Berger-Sweeney J (2007). Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Neuroscience 146: 907-921.
49. Tang SS, Fernandez D, Lazarou LP, Singh R, Fallon P (2012). MECP2 triplication in 3 brothers -a rarely described cause of familial neurological regression in boys. Eur J Paediatr Neurol 16: 209-212.
50. Tao J, Hu K, Chang Q, Wu H, Sherman NE, Martinowich K et al (2009). Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci USA 106: 4882-4887.
51. Traynor J, Agarwal P, Lazzeroni L, Francke U (2002). Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 3: 12.
52. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD et al (2009). Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 106: 2029-2034.
53. Tudor M, Akbarian S, Chen RZ, Jaenisch R (2002). Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 99: 15536-15541.
54. Van Esch H (2012). MECP2 Duplication Syndrome. Mol Syndromol 2: 128-136.
55. Weng SM, McLeod F, Bailey ME, Cobb SR (2011) Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal. Neuroscience 180: 314-321.
56. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF et al (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 102: 17551-17558.
57. Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L et al (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52: 255-269.
58. Zoghbi HY (2003) Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302: 826-830.